These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Citrate anticoagulation for continuous venovenous hemofiltration. Oudemans-van Straaten HM; Bosman RJ; Koopmans M; van der Voort PH; Wester JP; van der Spoel JI; Dijksman LM; Zandstra DF Crit Care Med; 2009 Feb; 37(2):545-52. PubMed ID: 19114912 [TBL] [Abstract][Full Text] [Related]
23. Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions. Cointault O; Kamar N; Bories P; Lavayssiere L; Angles O; Rostaing L; Genestal M; Durand D Nephrol Dial Transplant; 2004 Jan; 19(1):171-8. PubMed ID: 14671053 [TBL] [Abstract][Full Text] [Related]
24. Effect of anticoagulation regimens on handling of interleukin-6 and -8 during continuous venovenous hemofiltration in critically ill patients with acute kidney injury. Schilder L; Nurmohamed SA; ter Wee PM; Girbes AR; Beishuizen A; Paauw NJ; Beelen RH; Groeneveld AB Cytokine; 2012 Dec; 60(3):601-7. PubMed ID: 23006672 [TBL] [Abstract][Full Text] [Related]
25. Predilution versus postdilution continuous venovenous hemofiltration: no effect on filter life and azotemic control in critically ill patients on heparin. Nurmohamed SA; Jallah BP; Vervloet MG; Beishuizen A; Groeneveld AB ASAIO J; 2011; 57(1):48-52. PubMed ID: 21084966 [TBL] [Abstract][Full Text] [Related]
26. Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate. Gupta M; Wadhwa NK; Bukovsky R Am J Kidney Dis; 2004 Jan; 43(1):67-73. PubMed ID: 14712429 [TBL] [Abstract][Full Text] [Related]
27. Determinants of Calcium Infusion Rate During Continuous Veno-venous Hemofiltration with Regional Citrate Anticoagulation in Critically Ill Patients with Acute Kidney Injury. Liu DL; Huang LF; Ma WL; Ding Q; Han Y; Zheng Y; Li WX Chin Med J (Engl); 2016 Jul; 129(14):1682-7. PubMed ID: 27411455 [TBL] [Abstract][Full Text] [Related]
28. Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration. Hetzel GR; Taskaya G; Sucker C; Hennersdorf M; Grabensee B; Schmitz M Am J Kidney Dis; 2006 Nov; 48(5):806-11. PubMed ID: 17060000 [TBL] [Abstract][Full Text] [Related]
29. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Monchi M; Berghmans D; Ledoux D; Canivet JL; Dubois B; Damas P Intensive Care Med; 2004 Feb; 30(2):260-265. PubMed ID: 14600809 [TBL] [Abstract][Full Text] [Related]
30. An observational study on the effects of nadroparin-based and citrate-based continuous venovenous hemofiltration on calcium metabolism. van der Voort PH; Postma SR; Kingma WP; Boerma EC; de Heide LJ; Bakker AJ Blood Purif; 2007; 25(3):267-73. PubMed ID: 17446700 [TBL] [Abstract][Full Text] [Related]
31. Metabolic effects of citrate- vs bicarbonate-based substitution fluid in continuous venovenous hemofiltration: a prospective sequential cohort study. Aman J; Nurmohamed SA; Vervloet MG; Groeneveld AB J Crit Care; 2010 Mar; 25(1):120-7. PubMed ID: 19427760 [TBL] [Abstract][Full Text] [Related]
32. Simplified regional citrate anticoagulation protocol for CVVH, CVVHDF and SLED focused on the prevention of KRT-related hypophosphatemia while optimizing acid-base balance. Di Mario F; Sabatino A; Regolisti G; Pacchiarini MC; Greco P; Maccari C; Vizzini G; Italiano C; Pistolesi V; Morabito S; Fiaccadori E Nephrol Dial Transplant; 2023 Sep; 38(10):2298-2309. PubMed ID: 37037771 [TBL] [Abstract][Full Text] [Related]
33. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk. Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677 [TBL] [Abstract][Full Text] [Related]
34. A safe and effective protocol for postdilution hemofiltration with regional citrate anticoagulation. Dimski T; Brandenburger T; Vollmer C; Kindgen-Milles D BMC Nephrol; 2024 Jul; 25(1):218. PubMed ID: 38982339 [TBL] [Abstract][Full Text] [Related]
35. Simplified regional citrate anticoagulation using a calcium-containing replacement solution for continuous venovenous hemofiltration. Zhang L; Liao Y; Xiang J; Qin W; Wu X; Tang Y; Yang Y; Chen Z; Fu P J Artif Organs; 2013 Jun; 16(2):185-92. PubMed ID: 23271571 [TBL] [Abstract][Full Text] [Related]
36. Continuous venovenous hemofiltration with or without predilution regional citrate anticoagulation: a prospective study. Nurmohamed SA; Vervloet MG; Girbes AR; Ter Wee PM; Groeneveld AB Blood Purif; 2007; 25(4):316-23. PubMed ID: 17700015 [TBL] [Abstract][Full Text] [Related]
37. Negative calcium balance despite normal plasma ionized calcium concentrations during citrate anticoagulated continuous venovenous hemofiltration (CVVH) in ICU patients. de Jonge E; van der Vooren M; Gillis JMEP; Del Prado MR; Wigbers J; Bakhshi-Raiez F; Elzo Kraemer CV J Nephrol; 2023 May; 36(4):1019-1026. PubMed ID: 36342643 [TBL] [Abstract][Full Text] [Related]
38. Regional citrate anticoagulation versus low molecular weight heparin anticoagulation for continuous venovenous hemofiltration in patients with severe hypercalcemia: a retrospective cohort study. Yu Y; Bai M; Wei Z; Zhao L; Li Y; Ma F; Sun S Ren Fail; 2020 Nov; 42(1):748-758. PubMed ID: 32718221 [TBL] [Abstract][Full Text] [Related]
39. Management of regional citrate anticoagulation in pediatric high-flux dialysis: activated coagulation time versus post-filter ionized calcium. Kreuzer M; Ahlenstiel T; Kanzelmeyer N; Ehrich JH; Pape L Pediatr Nephrol; 2010 Jul; 25(7):1305-10. PubMed ID: 20221775 [TBL] [Abstract][Full Text] [Related]
40. Citrate anticoagulation during CVVH in high risk bleeding patients. Cubattoli L; Teruzzi M; Cormio M; Lampati L; Pesenti A Int J Artif Organs; 2007 Mar; 30(3):244-52. PubMed ID: 17417764 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]